Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that its controlling subsidiary, Chongqing Lifotronic Biotechnology Co., Ltd., recently received the Medical Device Registration Certificate of the People's Republic of China issued by the Chongqing Medical Products Administration for its product, the Photon Therapeutic Apparatus.
The registered Photon Therapeutic Apparatus is capable of emitting high-energy narrow-spectrum red light and blue light, and supports multiple treatment modes to meet the therapeutic needs of different users.
The product is suitable for patients requiring anti-inflammatory and analgesic treatment, as well as those needing to stop exudate from superficial wounds, promote granulation tissue growth, and accelerate wound healing. It can be used in a variety of settings including hospital departments, clinics, and homes.